Key points are not available for this paper at this time.
First-generation nanoparticles (NPs) have been clinically translated as pharmaceutical drug delivery carriers for their ability to improve on drug tolerability, circulation half-life, and efficacy. Toward the development of the next-generation NPs, researchers have designed novel multifunctional platforms for sustained release, molecular targeting, and environmental responsiveness. This review focuses on environmentally responsive mechanisms used in NP designs, and highlights the use of pH-responsive NPs in drug delivery. Different organs, tissues, and subcellular compartments, as well as their pathophysiological states, can be characterized by their pH levels and gradients. When exposed to these pH stimuli, pH-responsive NPs respond with physicochemical changes to their material structure and surface characteristics. These include swelling, dissociating or surface charge switching, in a manner that favors drug release at the target site over surrounding tissues. The novel developments described here may revise the classical outlook that NPs are passive delivery vehicles, in favor of responsive, sensing vehicles that use environmental cues to achieve maximal drug potency.
Building similarity graph...
Analyzing shared references across papers
Loading...
Gao et al. (Mon,) studied this question.
synapsesocial.com/papers/69dab08d4a1e15904c835bae — DOI: https://doi.org/10.1021/mp100253e
Weiwei Gao
Nankai University
Juliana M. Chan
Nanyang Technological University
Omid C. Farokhzad
AstraZeneca (United Kingdom)
Molecular Pharmaceutics
Massachusetts Institute of Technology
Brigham and Women's Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: